| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/18/2002 | CN1369279A 'Qiangjin Zhuanggu' pill and its preparing process |
| 09/18/2002 | CN1369276A Composition and method for effectively losing body weight |
| 09/18/2002 | CN1369270A Pearl shell capsule and its preparing process |
| 09/18/2002 | CN1091093C Higher fatty alcohol aliphatic ester and use thereof |
| 09/18/2002 | CN1091092C Retionic acid x-receptor ligands, its compsn. and usage |
| 09/18/2002 | CN1090967C Hypolipemic capsule |
| 09/18/2002 | CN1090939C Calcim iron concentration liquid and process for producing same |
| 09/17/2002 | US6452032 Organosilyl compounds having nuclear hormone receptor modulating activity |
| 09/17/2002 | US6451994 Polypeptides, polynucleotides; drug screening; diagnosing alzheimer*s, parkinson*s, huntington*s, and creutzfelt-jacob disease; amyotrophic lateral sclerosis, cystic fibrosis |
| 09/17/2002 | US6451860 Methods for treating depression and other disorders using optically pure (−)-bupropion |
| 09/17/2002 | US6451838 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/17/2002 | US6451836 Method of inhibiting liver glycogen phosphorylase with 2-alkylpyrrolidines |
| 09/17/2002 | US6451834 Indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole derivatives |
| 09/17/2002 | US6451808 Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists |
| 09/17/2002 | US6451804 Heteroalkylamino-substituted bicyclic nitrogen heterocycles |
| 09/17/2002 | US6451803 N-acyl and n-aroyl aralkyl amides useful in treating seritonergic disorders |
| 09/17/2002 | US6451802 S-oxide lipid lowering compounds |
| 09/17/2002 | US6451794 2,3-Diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2(COX-2) inhibitors |
| 09/17/2002 | US6451783 Administering to an obese patient or a patient at risk of becoming obese therapeutically effective amount of compound that attenuates binding of agouti-related protein to melanocortin receptors |
| 09/17/2002 | US6451734 Acts as a desiccant and/or defoliant; halogenation at the 4 position; also for lowering the blood sugar level, hypoglycemic agent |
| 09/17/2002 | US6451561 Growth hormone variants |
| 09/17/2002 | US6451360 Method for treating a subject afflicted with intestinal malabsorption |
| 09/17/2002 | US6451336 Method for increasing brown fat, comprising administering conjugated linoleic acid as active ingredient |
| 09/17/2002 | US6451310 Preventing t cell activation of b cells by administering antibody cabable of binding protein recognized by monoclonal antibody 5c8 |
| 09/17/2002 | US6451307 3′-exonuclease, production and use thereof |
| 09/17/2002 | US6451286 Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds |
| 09/17/2002 | CA2243459C Human antibodies that bind human tnf.alpha. |
| 09/17/2002 | CA2204151C Cdna encoding a bmp type ii receptor |
| 09/17/2002 | CA2038667C Process for the preparation of mannosyl teicoplanin derivatives and mannosyl teicoplanin aglycone |
| 09/16/2002 | CA2376844A1 Pyrazolo¢4,3-d!pyrimidin-7-ones and pyrazolo¢3,4!pyrimidin-4-ones and purinones which inhibit cgmp pdes |
| 09/12/2002 | WO2002070742A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 09/12/2002 | WO2002070741A2 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 09/12/2002 | WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | WO2002070698A2 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity |
| 09/12/2002 | WO2002070676A2 Use of protein histidine phosphatase |
| 09/12/2002 | WO2002070669A2 Secreted proteins |
| 09/12/2002 | WO2002070657A2 93870, a human g-protein coupled receptor and uses therefor |
| 09/12/2002 | WO2002070563A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070562A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070561A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070560A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070559A2 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | WO2002070558A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070557A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070532A2 C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses |
| 09/12/2002 | WO2002070522A1 Novel 2,5-diazabicyclo[2.2.1]heptane derivatives |
| 09/12/2002 | WO2002070520A1 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 09/12/2002 | WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | WO2002070509A2 Antagonists of mcp-1 function and methods of use thereof |
| 09/12/2002 | WO2002070507A2 Glycorticoid receptor antagonists for treatment of diabetes |
| 09/12/2002 | WO2002070502A1 Dimeric isoflavones |
| 09/12/2002 | WO2002070485A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/12/2002 | WO2002070484A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 09/12/2002 | WO2002070479A1 N-4-piperidinyl compounds as ccr5 modulators |
| 09/12/2002 | WO2002070473A2 Carboxamide derivatives as therapeutic agents |
| 09/12/2002 | WO2002070469A2 Selective pde3b inhibitors and use of the same in therapy |
| 09/12/2002 | WO2002070457A1 Inhibitor of monoamine uptake |
| 09/12/2002 | WO2002070016A2 Catecholate beta-lactam conjugates, method for producing the same and the use thereof |
| 09/12/2002 | WO2002070011A2 Treatment of ppar mediated diseases |
| 09/12/2002 | WO2002069997A1 Modified protamine with reduced immunogenicity |
| 09/12/2002 | WO2002069994A2 Combined use of derivatives of glp-1 analogs and ppar ligands |
| 09/12/2002 | WO2002069987A2 Agent for treating diabetes mellitus |
| 09/12/2002 | WO2002069977A1 Use of certain steroids for treatment of blood cell deficiencies |
| 09/12/2002 | WO2002069965A1 Benzimidazole derivatives as therapeutic agents |
| 09/12/2002 | WO2002069964A1 Enteral formulation |
| 09/12/2002 | WO2002069957A1 Fenofibrate-containing composition |
| 09/12/2002 | WO2002069689A2 Gssp4 polynucleotides and polypeptides and uses thereof |
| 09/12/2002 | WO2002026717A3 Hydroxy acid integrin antagonists |
| 09/12/2002 | WO2002022680A3 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 09/12/2002 | WO2002017735A3 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate |
| 09/12/2002 | WO2002014369A3 Human kininogen d5 domain polypeptides and their use |
| 09/12/2002 | WO2002012346A3 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 09/12/2002 | WO2002002096A3 Oral compositions comprising host-response modulating agent |
| 09/12/2002 | WO2001096334A3 Heteroarylalkanoic acids as integrin receptor antagonists |
| 09/12/2002 | WO2001089520A3 Dehydroascorbic acid formulations and uses thereof |
| 09/12/2002 | WO2001047509A3 Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions |
| 09/12/2002 | WO2001041768A9 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 09/12/2002 | WO2001036510A3 Use of poly(diallylamine) polymers |
| 09/12/2002 | WO2001030848A3 Nucleic acids of the human abc1 gene and applications thereof |
| 09/12/2002 | WO2000069901A3 Proteins with insulin-like activity useful in the treatment of diabetes |
| 09/12/2002 | US20020128475 Substituted and unsubstitued 9-arylsulfone- 1,2,3,4,5,6-hexahydroazepino (4,5-b) indoles are useful in treatment of depression, obesity and other central nervous system disorders |
| 09/12/2002 | US20020128471 Useful for treating cellular hyperproliferation |
| 09/12/2002 | US20020128436 Therapeutic composition for use in the treatment of autoimune and rheumatic diseases |
| 09/12/2002 | US20020128325 Process for producing dry powders of one or more carotenoids |
| 09/12/2002 | US20020128324 Process for decreasing adiposity using Vitamin A as a dietary supplement |
| 09/12/2002 | US20020128306 Programmed cell death; expansion of hematopoietic cells, for prolonging viability of an organ for transplantation, and maintaining viability of cell lines used in bioproduction |
| 09/12/2002 | US20020128302 Use of a CB1 receptor antagonist for the preparation of drugs useful in the treatment of appetency disorders, such as obesity associated with non-insulin- dependent diabetes and drug dependence |
| 09/12/2002 | US20020128298 Methods for increasing leptin levels using nicotinic acid compounds |
| 09/12/2002 | US20020128295 Hyperlipidemia, renal disease, proliferation or smooth muscle cells in the aorta, coronary artery occlusion, atherosclerosis, hypertension, advanced glycation end-product formation and advanced lipoxidation end-product formation. |
| 09/12/2002 | US20020128289 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action |
| 09/12/2002 | US20020128279 Potassium channel blocking agents |
| 09/12/2002 | US20020128278 Inhibit some of the ill effects caused by diabetes or by aging; preventing premature aging, rheumatoid arthritis, Alzheimer's disease, uremia, neurotoxicity, atherosclerosis and spoilage of proteins in food |
| 09/12/2002 | US20020128271 N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 09/12/2002 | US20020128266 ABCA-1 elevating compounds |
| 09/12/2002 | US20020128265 CRF receptor antagonists and methods relating thereto |
| 09/12/2002 | US20020128261 Cyclohepta [b] [1,4] diazepino [6,7, 1-hi] indoles and derivatives |
| 09/12/2002 | US20020128253 Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use |
| 09/12/2002 | US20020128252 Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use |
| 09/12/2002 | US20020128250 Modulating the expression of a gene |
| 09/12/2002 | US20020128247 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents |